Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Free Radicals
An Interactive App with Multi-parametric MRI - Whole-Mount Histology Correlation for Enhanced Prostate MRI Training of Radiology Residents.
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis.
The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma.
The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma. J Oncol Pract. 2016 10; 12(10):936-937.
View in:
PubMed
subject areas
Humans
Lung Neoplasms
Mesothelioma
Peritoneal Neoplasms
Rare Diseases
authors with profiles
Hedy Kindler